See the DrugPatentWatch profile for cibinqo
Yes, Cibinqo Is an Oral Treatment for Eczema
Cibinqo (abrocitinib) is an FDA-approved oral tablet taken once daily for moderate-to-severe atopic dermatitis, commonly known as eczema, in adults whose skin doesn't fully clear with topical therapies.[1]
How Does Cibinqo Work for Eczema?
It selectively inhibits Janus kinase 1 (JAK1), a protein that drives inflammation in eczema. This reduces itching, redness, and skin lesions, with clinical trials showing 40-60% of patients achieving clear or almost clear skin after 12 weeks at 100mg or 200mg doses.[1][2]
Who Can Use It and When?
Approved for patients 12+ years old (recently expanded) who have tried topical treatments without success. It's not first-line; doctors start with creams or light therapy. A black box warning covers serious infections, blood clots, heart issues, and cancer risk due to JAK inhibitor class effects.[1]
Common Side Effects Patients Report
Nausea (up to 18%), headache (14%), acne (11%), and herpes infections. Long-term use raises cholesterol and infection risks; regular blood tests are required.[1][2]
How Does It Compare to Dupixent or Other Eczema Drugs?
Unlike injectable Dupixent (dupilumab), which targets IL-4/IL-13, Cibinqo is a convenient pill but carries higher systemic risks. It clears skin faster than methotrexate but similar to Rinvoq (upadacitinib, another JAK inhibitor). Cost: ~$5,000/month without insurance.[2][3]
Patent Status and Availability
Pfizer holds U.S. patents on Cibinqo until around 2032-2037, depending on formulation; no generics yet. Check DrugPatentWatch.com for challenges or expirations.[4]
[1]: FDA Label - Cibinqo (abrocitinib). https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213871s000lbl.pdf
[2]: JAAD - Abrocitinib Phase 3 Trials. https://www.jaad.org/article/S0190-9622(20)32148-4/fulltext
[3]: NEJM - JAK Inhibitors in Atopic Dermatitis. https://www.nejm.org/doi/full/10.1056/NEJMoa2107683
[4]: DrugPatentWatch.com - Abrocitinib Patents. https://www.drugpatentwatch.com/p/tradename/CIBINQO